InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Hanson Kristopher, Chief Executive Officer. Insider active across 2 companies, notably PhaseBio Pharmaceuticals Inc. In total, 5 disclosures have been published. Activity tracked since 20 May 2021. The latest transaction was filed on 20 May 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
4,831 shares@ US$0.681328.1% of flowCommon StockSEC:0001169245-22-000076:0
1,545 shares@ US$2.0124.7% of flowCommon StockSEC:0001169245-21-000126:0
1,545 shares@ US$2.0124.7% of flowCommon StockSEC:0001169245-21-000126
1,088 shares@ US$2.80100.0% of flowCommon StockSEC:0001169245-21-000042
1,088 shares@ US$2.8022.5% of flowCommon StockSEC:0001169245-21-000042:0
5 of 5 declarations
About Hanson Kristopher
Kristopher Hanson is the Vice President, Head of Legal, and General Counsel of PhaseBio Pharmaceuticals Inc. He is responsible for managing the legal affairs of the company. His role is essential in ensuring regulatory compliance and protecting the company's interests.
